Company: DARE
Filing Date: 2025-06-25
Form Type: 8-K
Source: 0001641172-25-016374
Chunk: 2

Company: Dare Bioscience, Inc.
Filing Date: 2025-06-25
Form: 8-K
Item: Item 8.01
Chunk 2
---
 to regain compliance with Nasdaq Listing Rule 5550(b)
and the risk factors discussed in Item 1A of Part II of Daré’s quarterly report on Form 10-Q and Item 1A of Part I of Daré’s
annual report on Form 10-K filed with the SEC on May 13, 2025 and March 31, 2025, respectively, as such factors may be updated from time
to time in Daré’s other filings with the SEC. Forward-looking statements are based upon Daré’s current expectations
and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified
in their entirety by these cautionary statements. For a detailed description of Daré’s risks and uncertainties, you are encouraged
to review its documents filed with the SEC including Daré’s recent filings on Form 8-K, Form 10-K and Form 10-Q. You are cautioned
not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Daré undertakes
no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made,
except as required by law.

  -2-  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                     DARÉ                                               
  Dated:             By:                   /s/                          
                     Name:                 Sabrina                      
                     Title:                President                    

  -3-